A new pill in the U.S. offers hope to mothers with postpartum depression
Zuranolone, which will be marketed under the brand name Zurzuvae, is the first pill developed specifically to treat postpartum depression — and maternal mental health experts say it has the potential to completely transform how the condition is treated.